Pharmacological Targeting Of Mutant p53 Gain-of-Function Represses Mevalonate Pathway Of Cholesterol Biosynthesis And Sensitizes Tumor Cells To Radiation
Year: 2020
Type: article
Authors: A. Nikolaev, D. Tong, C. Xing, L. Zeng, C. Prives, J.A. Bonner, E.S. Yang
Institutions: University of Alabama at Birmingham, Columbia University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3094534057
